New Mexico Administrative Code

When a disciplinary action is taken under part 23 solely because the applicant or licensee is not in compliance with a judgment and order for support, the board's order shall state that the application or license shall be reinstated upon presentation of a subsequent statement of …

Proceedings under this part shall be governed by the Uniform Licensing Act, NMSA 1978, Section 61-1-1 through 61-1-31.

All persons subject to licensure or registration by the board of pharmacy.

Section 61-11-6(A)(1) of the Pharmacy Act directs the board of pharmacy to adopt, regularly review and revise rules and regulations necessary to carry out the provisions of the Pharmacy Act after hearings open to the public. The board adopts part 23 of Chapter 19 pursuant to the …

Permanent.

October 14, 1995, unless a later date is cited at the end of a Section or Paragraph.

The objective of part 23 of Chapter 19 is to ensure compliance with the Parental Responsibility Act by all persons licensed by, registered with, applying for licensure or registration from, the board of pharmacy.

A. "Applicant" means an individual seeking a license or registration issued by the board of pharmacy pursuant to either the Pharmacy Act, Controlled Substance Act or Drug Precursor Act. B. "HSD" means the New Mexico Human Services Department. C. "License" means a license or regis…

If an applicant or licensee is not in compliance with a judgment and order for support, the board: A. shall deny an application for a license; B. shall deny the renewal of a license; and C. has grounds for suspension or revocation of the license.

HSD shall provide the board with a certified list of obligors not in compliance with a judgement and order for child support on a monthly basis. The board shall report to HSD the names of applicants and licensees who are on the certified list and the action the board has taken in…

Regulation and Licensing Department Board of Pharmacy, 1650 University Blvd, NE - Ste. 400B, Albuquerque, NM 87102, (505) 841-9102.

Any EMS licensed by the Board is required to have a consultant pharmacist as defined in 16 NMAC 19.4.11. In addition, the consultant pharmacist shall: A. review all instances in which controlled substances were used, and review all or a sample of instances in which other drugs we…

A. All dangerous drugs must be stored with appropriate security to limit access when authorized personnel are not present. Extra precautions shall be provided for security of controlled substances. B. Jump kits shall be kept in the possession of a licensed emergency practitioner …

A. EMS drug administration shall be limited to drugs currently authorized by scopes of practice for EMS personnel. Each licensee shall provide a formulary to the Board on an annual basis or as changes occur. B. EMS shall keep an up to date record in readily retrievable format for…

Fees for initial and renewal applications are listed in 16.19.12.15.1.4 NMAC.

A. EMS Training facilities. Injury Prevention and EMS Bureau of the Department of Health will be licensed by the Board. B. Pre-licensing inspections and fees for licensure will be waived. C. EMS Training Facilities will conduct periodic (no less that quarterly) inventories of dan…

All Emergency Medical Services Providers (EMS) that operate in the State and administer drugs. Other rules applying to EMS drug use are found in 7.27.3 NMAC.

Section 61-11-6(A) NMSA 1978 requires the Board of Pharmacy to provide for the licensing of EMSs and for the inspection of their facilities and activities. Pursuant to 61-11-14(B) 11 the Board is authorized to issue licenses for EMSs. Section 26-1-16(A) NMSA 1978 prohibits the sa…

Permanent.

December 15, 1999, unless a later date is cited at the end of a Section.

To ensure the safe and competent maintenance, and administration of drugs by EMS.

All terms defined in the Pharmacy Act or elsewhere in the Board regulations shall have the same meanings in this regulation unless otherwise defined as follows: A. "Emergency Medical Service" or "EMS" refers to an organization which: transports patients and/or in which patient ca…

A. The Medical Director shall specify the dangerous drugs to be used in such service. B. The Medical Director shall develop protocols for use of medical procedures and dangerous drugs.

In order to purchase and stock any controlled substance, the EMS must obtain separate Drug Enforcement Administration (DEA) and state of New Mexico controlled substance registrations to be issued under the name of the service.

Regulation and Licensing Department - Board of Pharmacy, Albuquerque, NM, (505) 841-9102.

All persons or entities that dispense, administer, deliver or conduct research using dangerous drugs.

Section 61-11-2 DD defines significant adverse drug event. Section 61-11-18.1 NMSA 1978 authorizes the Board of pharmacy to promulgate regulations regarding the prevention and reporting of significant adverse drug events.

Permanent.

March 30, 2002, unless a later date is cited in the history note at the end of a section.

The objective of Part 25 of Chapter 19 is to protect the health and welfare of the citizens of the State of New Mexico against significant adverse drug events.

A. "Significant Adverse Drug Event" means a drug related incident that results in harm to the patient. B. "Incident" means a drug that is dispensed in error, that is administered and results in harm, injury or death. C. "Dispensing Error" means a prescription that was dispensed f…

A. Develop and implement written error prevention procedures as part of the Policy and Procedures Manual. B. Report incidents, including relevant status updates, to the Board on Board approved forms within fifteen (15) days of discovery.

A. Maintain confidentiality of information relating to the reporter and the patient identifiers. B. Compile and publish, in the newsletter and on the Board web site, report information and prevention recommendations. C. Assure reports are used in a constructive and non-punitive m…

Board of Pharmacy.

A. Protocol: (1) Prescriptive authority for tobacco cessation drug therapy shall be exercised solely in accordance with the written protocol for tobacco cessation drug therapy approved by the board. (2) Any pharmacist exercising prescriptive authority for tobacco cessation drug t…

A. Protocol: (1) Prescriptive authority for Tuberculosis (TB) testing shall be exercised solely in accordance with the written protocol for TB testing drug therapy approved by the board. (2) Any pharmacist exercising prescriptive authority for TB testing must maintain a current c…

A. Protocol: (1) Prescriptive authority for naloxone drug therapy shall be exercised solely in accordance with the written protocol for naloxone drug therapy approved by the board. (2) Any pharmacist exercising prescriptive authority for naloxone drug therapy must maintain a curr…

A. Protocol: (1) Prescriptive authority for hormonal contraception drug therapy shall be exercised solely in accordance with the written protocol for hormonal contraception drug therapy approved by the board. (2) Any pharmacist exercising prescriptive authority for hormonal contr…

A. Protocol: (1) Prescriptive authority shall be exercised solely in accordance with the written protocol for prescribing of dangerous drugs in conjunction with point-of-care testing (POCT) approved by the board. (2) Any pharmacist exercising prescriptive authority for prescribin…

All pharmacists that intend to exercise the authority to prescribe dangerous drugs based on written protocols approved by the Board.

Paragraph (1) of Subsection A of Section 61-11-6 NMSA 1978 authorizes the board of Pharmacy to adopt, regularly review and revise rules and regulations necessary to carry out the provisions of the Pharmacy Act. Paragraph (7) of Subsection A of Section 61-11-6 NMSA 1978 gives the …

Permanent.

12-15-02, unless a later date is cited at the end of a section.

The objective of Part 26 of Chapter 19 is to protect the health and safety of New Mexico citizens by regulating the prescriptive authority of pharmacists.

A. "Antigen" means a substance recognized by the body as being foreign; it results in the production of specific antibodies directed against it. B. "Antibody" means a protein in the blood that is produced in response to stimulation by a specific antigen. C. "Immunization" means t…

Any pharmacist not certified to provide a prescriptive authority service is required to refer patients to a pharmacist or other provider who provides such a service.

A. Protocol: (1) Prescriptive authority for vaccines shall be exercised solely in accordance with the written protocol for vaccine prescriptive authority approved by the board. (2) Any pharmacist exercising prescriptive authority for vaccines must maintain a current copy of the p…

Board of Pharmacy.

Pharmacist interns, pharmacy technicians and businesses licensed pursuant to the New Mexico Pharmacy Act.

Paragraph (1) of Subsection A of Section 61-11-6 NMSA, 1978 authorizes the board of pharmacy to adopt, regularly review and revise rules and regulations necessary to carry out the provisions of the Pharmacy Act. Paragraph (7) of Subsection A of Section 61-11-6 NMSA 1978 authorize…